Osteosarcoma in pre-adolescent patients

Journal of International Medical Research

Volumn 34, Issue 6, 2006, Pages 676-681

  Cho, W H ^a   Lee, S Y ^a   Song, W S ^a   Park, J H ^a  

^a Korea Cancer Center Hospital   (South Korea)

Author keywords

Adolescence; Chemotherapy; Osteosarcoma; Paeditrics; Pre adolescence; Prognostic factors; Surgery

Indexed keywords

ALKALINE PHOSPHATASE; BLEOMYCIN; CISPLATIN; DOXORUBICIN; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE;

ADOLESCENT; ALKALINE PHOSPHATASE BLOOD LEVEL; AMPUTATION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER SIZE; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; GENDER; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OSTEOSARCOMA; PROGNOSIS; SCHOOL CHILD; TUMOR NECROSIS;

EID: 33846522434     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000603400614     Document Type: Article

References (22)

1. Gurney JG, Severson RK, Davis S, Robison LL: Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995; 75: 2186-2195.
2. Chessells JM, Hall E, Prentice HG, Durrant J, Bailey CC, Richards SM: The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties. Leukemia 1998; 12: 463-473.
3. Weinstein JL, Katzenstein HM, Cohn SL: Advances in the diagnosis and treatment of neuroblastoma. Oncologist 2003; 8: 278-292.
4. Herson J, Sutow WW, Elder K, Vietti TJ, Falletta JM, Crist WM, et al: Adjuvant chemotherapy in nonmetastatic osteosarcoma: a Southwest Oncology Group Study. Med Pediatr Oncol 1980; 8: 343-352.
5. Hudson M, Jaffe MR, Jaffe N, Ayala A, Raymond AK, Carrasco H, et al: Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience. J Clin Oncol 1990; 8: 1988-1997.
6. Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ, et al: Treatment of non-metastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 1997; 15: 76-84.
7. Rytting M, Pearson P, Raymond AK, Ayala A, Murray J, Yasko AW, et al: Osteosarcoma in preadolescent patients. Clin Orthop Relat Res 2000; 373: 39-50.
8. Brostrom LA, Strander H, Nilsonne U: Survival in osteosarcoma in relation to tumor size and location. Clin Orthop Relat Res 1982; 167: 250-254.
9. Winkler K, Beron G, Kotz R, Salzer-Kuntschik M, Beck J, Beck W, et al: Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study. J Clin Oncol 1984; 2: 617-624.
10. Bacci G, Picci P, Ferrari S, Orlandi M, Ruggieri P, Casadei R, et al: Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy. Cancer 1993; 71: 1224-1230.
11. Levine AM, Rosenberg SA: Alkaline phosphatase levels in osteosarcoma tissue are related to prognosis. Cancer 1979; 44: 2291-2293.
12. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, et al: Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982; 49: 1221-1230.
13. Thorpe WP, Reilly JJ, Rosenberg SA: Prognostic significance of alkaline phosphatase measurements in patients with osteogenic sarcoma receiving chemotherapy. Cancer 1979, 43: 2178-2181.
14. Petrilli AS, Gentil FC, Epelman S, Lopes LF, Bianchi A, Lopes A, et al: Increases survival, limb preservation, and prognostic factors for osteosarcoma. Cancer 1991; 68: 733-737.
15. Winkler K, Beron G, Delling G, Heise U, Kabisch H, Purfurst C, et al: Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 1988; 6: 329-337.
16. Burgers JM, van Glabbeke M, Busson A, Cohen P, Mazabraud AR, Abbatucci JS, et al: Osteosarcoma of the limbs. Report of the EORTC-SIOP 03 trial 20781 investigating the value of adjuvant treatment with chemotherapy and/or prophylactic lung irradiation. Cancer 1988; 61: 1024-1031.
17. Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res 1986; 204: 9-24.
18. Dahlin DC, Unni KK: Osteosarcoma of bone and its important recognizable varieties. Am J Surg Pathol 1977; 1: 61-72.
19. Kozakewich H, Perez-Atayde AR, Goorin AM, Wilkinson RH, Gebhardt MC, Vawter GF: Osteosarcoma in young children. Cancer 1991; 67: 638-642.
20. Scranton PE Jr, DeCicco FA, Totten RS, Yunis EJ: Prognostic factors in osteosarcoma; A review of 20 years' experience at the University of Pittsburgh Health Center Hospitals. Cancer 1975; 36: 2179-2191.
21. Picci P, Sangiorgi L, Rougraff BT, Neff JR, Casadei R, Campanacci M: Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in esteosarcoma. J Clin Oncol 1994; 12: 2699-2705.
22. Bacci G, Longhi A, Bertoni: F, Bacchini P, Ruggerei P, Versari M, et al: Primary high-grade osteosarcoma: comparison between pre-adolescent and older patients. J Pediatr Hematol Oncol 2005; 27: 129-134.